nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR3—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00955	0.0221	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00915	0.0212	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00886	0.0205	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.00858	0.0199	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00849	0.0197	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.00822	0.0191	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00812	0.0188	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.0076	0.0176	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00759	0.0176	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00753	0.0175	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00749	0.0174	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.00729	0.0169	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00728	0.0169	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.007	0.0162	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00695	0.0161	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00695	0.0161	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.00673	0.0156	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00667	0.0155	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00645	0.015	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.00623	0.0144	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.00622	0.0144	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.00597	0.0139	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00596	0.0138	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00596	0.0138	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00591	0.0137	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00578	0.0134	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00575	0.0133	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.00573	0.0133	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00571	0.0132	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00554	0.0128	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00552	0.0128	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00546	0.0126	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.0053	0.0123	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00506	0.0117	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00492	0.0114	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00489	0.0113	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.00489	0.0113	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.00475	0.011	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00467	0.0108	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00454	0.0105	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00454	0.0105	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00451	0.0105	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CCL11—allergic rhinitis	0.00438	0.0102	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00435	0.0101	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CCL11—allergic rhinitis	0.0042	0.00974	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00418	0.00969	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00401	0.00929	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.00389	0.00902	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00386	0.00894	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CCL11—allergic rhinitis	0.00372	0.00864	CbGpPWpGaD
Pasireotide—Insomnia—Cyproheptadine—allergic rhinitis	0.00358	0.0063	CcSEcCtD
Pasireotide—Nasopharyngitis—Montelukast—allergic rhinitis	0.00356	0.00626	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00356	0.00825	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00355	0.00824	CbGpPWpGaD
Pasireotide—Vertigo—Dimenhydrinate—allergic rhinitis	0.00355	0.00624	CcSEcCtD
Pasireotide—Vertigo—Diphenhydramine—allergic rhinitis	0.00355	0.00624	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Montelukast—allergic rhinitis	0.00351	0.00618	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Desloratadine—allergic rhinitis	0.00351	0.00617	CcSEcCtD
Pasireotide—Insomnia—Desloratadine—allergic rhinitis	0.00348	0.00612	CcSEcCtD
Pasireotide—Decreased appetite—Cyproheptadine—allergic rhinitis	0.00344	0.00605	CcSEcCtD
Pasireotide—Influenza—Montelukast—allergic rhinitis	0.00344	0.00605	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CCL11—allergic rhinitis	0.00344	0.00797	CbGpPWpGaD
Pasireotide—Fatigue—Cyproheptadine—allergic rhinitis	0.00341	0.006	CcSEcCtD
Pasireotide—Constipation—Cyproheptadine—allergic rhinitis	0.00339	0.00596	CcSEcCtD
Pasireotide—Decreased appetite—Desloratadine—allergic rhinitis	0.00335	0.00589	CcSEcCtD
Pasireotide—Fatigue—Desloratadine—allergic rhinitis	0.00332	0.00584	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00328	0.0076	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00327	0.00757	CbGpPWpGaD
Pasireotide—Oedema peripheral—Cetirizine—allergic rhinitis	0.00324	0.00569	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—TAC1—allergic rhinitis	0.00318	0.00738	CbGpPWpGaD
Pasireotide—Oedema peripheral—Flunisolide—allergic rhinitis	0.00318	0.0056	CcSEcCtD
Pasireotide—Gastrointestinal pain—Desloratadine—allergic rhinitis	0.00315	0.00554	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00313	0.00726	CbGpPWpGaD
Pasireotide—Alopecia—Loratadine—allergic rhinitis	0.00309	0.00543	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—TAC1—allergic rhinitis	0.00305	0.00707	CbGpPWpGaD
Pasireotide—Abdominal pain—Desloratadine—allergic rhinitis	0.00304	0.00535	CcSEcCtD
Pasireotide—Hypotension—Diphenhydramine—allergic rhinitis	0.00301	0.00529	CcSEcCtD
Pasireotide—Hypotension—Dimenhydrinate—allergic rhinitis	0.00301	0.00529	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00297	0.00688	CbGpPWpGaD
Pasireotide—Insomnia—Dimenhydrinate—allergic rhinitis	0.00291	0.00512	CcSEcCtD
Pasireotide—Insomnia—Diphenhydramine—allergic rhinitis	0.00291	0.00512	CcSEcCtD
Pasireotide—Alopecia—Cetirizine—allergic rhinitis	0.0029	0.00511	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00284	0.00659	CbGpPWpGaD
Pasireotide—Asthenia—Cyproheptadine—allergic rhinitis	0.00284	0.005	CcSEcCtD
Pasireotide—Fatigue—Olopatadine—allergic rhinitis	0.00284	0.00499	CcSEcCtD
Pasireotide—Decreased appetite—Diphenhydramine—allergic rhinitis	0.0028	0.00492	CcSEcCtD
Pasireotide—Decreased appetite—Dimenhydrinate—allergic rhinitis	0.0028	0.00492	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00278	0.00644	CbGpPWpGaD
Pasireotide—Fatigue—Diphenhydramine—allergic rhinitis	0.00278	0.00488	CcSEcCtD
Pasireotide—Fatigue—Dimenhydrinate—allergic rhinitis	0.00278	0.00488	CcSEcCtD
Pasireotide—Back pain—Cetirizine—allergic rhinitis	0.00277	0.00487	CcSEcCtD
Pasireotide—Asthenia—Desloratadine—allergic rhinitis	0.00276	0.00486	CcSEcCtD
Pasireotide—Constipation—Diphenhydramine—allergic rhinitis	0.00275	0.00484	CcSEcCtD
Pasireotide—Constipation—Dimenhydrinate—allergic rhinitis	0.00275	0.00484	CcSEcCtD
Pasireotide—Pruritus—Desloratadine—allergic rhinitis	0.00272	0.00479	CcSEcCtD
Pasireotide—Back pain—Flunisolide—allergic rhinitis	0.00272	0.00478	CcSEcCtD
Pasireotide—Diarrhoea—Cyproheptadine—allergic rhinitis	0.00271	0.00477	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—TAC1—allergic rhinitis	0.00271	0.00627	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Olopatadine—allergic rhinitis	0.00269	0.00473	CcSEcCtD
Pasireotide—Diarrhoea—Desloratadine—allergic rhinitis	0.00263	0.00463	CcSEcCtD
Pasireotide—Hypertension—Loratadine—allergic rhinitis	0.00262	0.00462	CcSEcCtD
Pasireotide—Dizziness—Cyproheptadine—allergic rhinitis	0.00262	0.00461	CcSEcCtD
Pasireotide—Abdominal pain—Olopatadine—allergic rhinitis	0.0026	0.00458	CcSEcCtD
Pasireotide—Myalgia—Loratadine—allergic rhinitis	0.00259	0.00455	CcSEcCtD
Pasireotide—Vertigo—Cetirizine—allergic rhinitis	0.00257	0.00452	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00256	0.00594	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00256	0.00594	CbGpPWpGaD
Pasireotide—Dizziness—Desloratadine—allergic rhinitis	0.00255	0.00448	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisolone—allergic rhinitis	0.00253	0.00445	CcSEcCtD
Pasireotide—Vertigo—Flunisolide—allergic rhinitis	0.00253	0.00444	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00252	0.00585	CbGpPWpGaD
Pasireotide—Vomiting—Cyproheptadine—allergic rhinitis	0.00252	0.00443	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—TAC1—allergic rhinitis	0.0025	0.00579	CbGpPWpGaD
Pasireotide—Headache—Cyproheptadine—allergic rhinitis	0.00248	0.00436	CcSEcCtD
Pasireotide—Diabetes mellitus—Hydrocortisone—allergic rhinitis	0.00247	0.00435	CcSEcCtD
Pasireotide—Hypertension—Cetirizine—allergic rhinitis	0.00247	0.00434	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00246	0.0057	CbGpPWpGaD
Pasireotide—Vomiting—Desloratadine—allergic rhinitis	0.00245	0.0043	CcSEcCtD
Pasireotide—Arthralgia—Cetirizine—allergic rhinitis	0.00243	0.00428	CcSEcCtD
Pasireotide—Myalgia—Cetirizine—allergic rhinitis	0.00243	0.00428	CcSEcCtD
Pasireotide—Hypertension—Flunisolide—allergic rhinitis	0.00243	0.00427	CcSEcCtD
Pasireotide—Anxiety—Cetirizine—allergic rhinitis	0.00243	0.00427	CcSEcCtD
Pasireotide—Headache—Desloratadine—allergic rhinitis	0.00241	0.00424	CcSEcCtD
Pasireotide—Myalgia—Flunisolide—allergic rhinitis	0.00239	0.00421	CcSEcCtD
Pasireotide—Anxiety—Flunisolide—allergic rhinitis	0.00239	0.0042	CcSEcCtD
Pasireotide—Asthenia—Olopatadine—allergic rhinitis	0.00236	0.00415	CcSEcCtD
Pasireotide—Nausea—Cyproheptadine—allergic rhinitis	0.00235	0.00414	CcSEcCtD
Pasireotide—Pruritus—Olopatadine—allergic rhinitis	0.00233	0.0041	CcSEcCtD
Pasireotide—Diabetes mellitus—Triamcinolone—allergic rhinitis	0.00233	0.00409	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00233	0.0054	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00233	0.0054	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.00233	0.00539	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Methylprednisolone—allergic rhinitis	0.00232	0.00409	CcSEcCtD
Pasireotide—Hypotension—Loratadine—allergic rhinitis	0.00232	0.00408	CcSEcCtD
Pasireotide—Asthenia—Diphenhydramine—allergic rhinitis	0.00231	0.00406	CcSEcCtD
Pasireotide—Asthenia—Dimenhydrinate—allergic rhinitis	0.00231	0.00406	CcSEcCtD
Pasireotide—Nausea—Desloratadine—allergic rhinitis	0.00229	0.00402	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Loratadine—allergic rhinitis	0.00226	0.00397	CcSEcCtD
Pasireotide—Diarrhoea—Olopatadine—allergic rhinitis	0.00225	0.00396	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CCL11—allergic rhinitis	0.00225	0.00521	CbGpPWpGaD
Pasireotide—Insomnia—Loratadine—allergic rhinitis	0.00224	0.00395	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00223	0.00517	CbGpPWpGaD
Pasireotide—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.0022	0.00388	CcSEcCtD
Pasireotide—Diarrhoea—Diphenhydramine—allergic rhinitis	0.0022	0.00388	CcSEcCtD
Pasireotide—Hypotension—Cetirizine—allergic rhinitis	0.00218	0.00384	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00218	0.00505	CbGpPWpGaD
Pasireotide—Dizziness—Olopatadine—allergic rhinitis	0.00218	0.00383	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CCL11—allergic rhinitis	0.00216	0.005	CbGpPWpGaD
Pasireotide—Fatigue—Loratadine—allergic rhinitis	0.00214	0.00376	CcSEcCtD
Pasireotide—Dizziness—Diphenhydramine—allergic rhinitis	0.00213	0.00375	CcSEcCtD
Pasireotide—Dizziness—Dimenhydrinate—allergic rhinitis	0.00213	0.00375	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Cetirizine—allergic rhinitis	0.00213	0.00374	CcSEcCtD
Pasireotide—Constipation—Loratadine—allergic rhinitis	0.00212	0.00373	CcSEcCtD
Pasireotide—Diabetes mellitus—Betamethasone—allergic rhinitis	0.00211	0.00371	CcSEcCtD
Pasireotide—Diabetes mellitus—Dexamethasone—allergic rhinitis	0.00211	0.00371	CcSEcCtD
Pasireotide—Insomnia—Cetirizine—allergic rhinitis	0.00211	0.00371	CcSEcCtD
Pasireotide—Vomiting—Olopatadine—allergic rhinitis	0.00209	0.00368	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Flunisolide—allergic rhinitis	0.00209	0.00368	CcSEcCtD
Pasireotide—Insomnia—Flunisolide—allergic rhinitis	0.00208	0.00365	CcSEcCtD
Pasireotide—Headache—Olopatadine—allergic rhinitis	0.00206	0.00363	CcSEcCtD
Pasireotide—Vomiting—Dimenhydrinate—allergic rhinitis	0.00205	0.0036	CcSEcCtD
Pasireotide—Vomiting—Diphenhydramine—allergic rhinitis	0.00205	0.0036	CcSEcCtD
Pasireotide—Arthralgia—Montelukast—allergic rhinitis	0.00204	0.00359	CcSEcCtD
Pasireotide—Myalgia—Montelukast—allergic rhinitis	0.00204	0.00359	CcSEcCtD
Pasireotide—Anxiety—Montelukast—allergic rhinitis	0.00203	0.00358	CcSEcCtD
Pasireotide—Decreased appetite—Cetirizine—allergic rhinitis	0.00203	0.00357	CcSEcCtD
Pasireotide—Gastrointestinal pain—Loratadine—allergic rhinitis	0.00203	0.00357	CcSEcCtD
Pasireotide—Dry skin—Prednisolone—allergic rhinitis	0.00202	0.00355	CcSEcCtD
Pasireotide—Headache—Diphenhydramine—allergic rhinitis	0.00202	0.00355	CcSEcCtD
Pasireotide—Headache—Dimenhydrinate—allergic rhinitis	0.00202	0.00355	CcSEcCtD
Pasireotide—Fatigue—Cetirizine—allergic rhinitis	0.00201	0.00354	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00201	0.00466	CbGpPWpGaD
Pasireotide—Constipation—Cetirizine—allergic rhinitis	0.002	0.00351	CcSEcCtD
Pasireotide—Decreased appetite—Flunisolide—allergic rhinitis	0.002	0.00351	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00198	0.00459	CbGpPWpGaD
Pasireotide—Fatigue—Flunisolide—allergic rhinitis	0.00198	0.00348	CcSEcCtD
Pasireotide—Dry skin—Hydrocortisone—allergic rhinitis	0.00197	0.00347	CcSEcCtD
Pasireotide—Abdominal pain upper—Hydrocortisone—allergic rhinitis	0.00196	0.00345	CcSEcCtD
Pasireotide—Constipation—Flunisolide—allergic rhinitis	0.00196	0.00345	CcSEcCtD
Pasireotide—Abdominal pain—Loratadine—allergic rhinitis	0.00196	0.00345	CcSEcCtD
Pasireotide—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.00196	0.00344	CcSEcCtD
Pasireotide—Nausea—Olopatadine—allergic rhinitis	0.00196	0.00344	CcSEcCtD
Pasireotide—Abdominal distension—Prednisolone—allergic rhinitis	0.00192	0.00337	CcSEcCtD
Pasireotide—Nausea—Diphenhydramine—allergic rhinitis	0.00191	0.00336	CcSEcCtD
Pasireotide—Nausea—Dimenhydrinate—allergic rhinitis	0.00191	0.00336	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CCL11—allergic rhinitis	0.00191	0.00443	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.00191	0.00336	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.0019	0.00441	CbGpPWpGaD
Pasireotide—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.0019	0.00334	CcSEcCtD
Pasireotide—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.00188	0.0033	CcSEcCtD
Pasireotide—Abdominal distension—Hydrocortisone—allergic rhinitis	0.00187	0.00329	CcSEcCtD
Pasireotide—Abdominal pain—Cetirizine—allergic rhinitis	0.00185	0.00324	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00183	0.00423	CbGpPWpGaD
Pasireotide—Abdominal pain—Flunisolide—allergic rhinitis	0.00181	0.00319	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—TAC1—allergic rhinitis	0.0018	0.00417	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.00178	0.00314	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.00178	0.00313	CcSEcCtD
Pasireotide—Asthenia—Loratadine—allergic rhinitis	0.00178	0.00313	CcSEcCtD
Pasireotide—Insomnia—Montelukast—allergic rhinitis	0.00177	0.00311	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CCL11—allergic rhinitis	0.00176	0.00409	CbGpPWpGaD
Pasireotide—Abdominal distension—Triamcinolone—allergic rhinitis	0.00176	0.0031	CcSEcCtD
Pasireotide—Abdominal distension—Methylprednisolone—allergic rhinitis	0.00176	0.00309	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—PTGDR2—allergic rhinitis	0.00175	0.00406	CbGpPWpGaD
Pasireotide—Influenza—Triamcinolone—allergic rhinitis	0.00175	0.00308	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—TAC1—allergic rhinitis	0.00172	0.004	CbGpPWpGaD
Pasireotide—Diarrhoea—Loratadine—allergic rhinitis	0.0017	0.00298	CcSEcCtD
Pasireotide—Fatigue—Montelukast—allergic rhinitis	0.00169	0.00297	CcSEcCtD
Pasireotide—Dry skin—Betamethasone—allergic rhinitis	0.00168	0.00296	CcSEcCtD
Pasireotide—Dry skin—Dexamethasone—allergic rhinitis	0.00168	0.00296	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—PTGDR2—allergic rhinitis	0.00168	0.00389	CbGpPWpGaD
Pasireotide—Asthenia—Cetirizine—allergic rhinitis	0.00167	0.00295	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—IL5—allergic rhinitis	0.00167	0.00388	CbGpPWpGaD
Pasireotide—Hypokalaemia—Betamethasone—allergic rhinitis	0.00167	0.00294	CcSEcCtD
Pasireotide—Hypokalaemia—Dexamethasone—allergic rhinitis	0.00167	0.00294	CcSEcCtD
Pasireotide—Pruritus—Cetirizine—allergic rhinitis	0.00165	0.0029	CcSEcCtD
Pasireotide—Asthenia—Flunisolide—allergic rhinitis	0.00165	0.0029	CcSEcCtD
Pasireotide—Dizziness—Loratadine—allergic rhinitis	0.00164	0.00288	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—TAC1—allergic rhinitis	0.00163	0.00379	CbGpPWpGaD
Pasireotide—Pruritus—Flunisolide—allergic rhinitis	0.00162	0.00286	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—IL5—allergic rhinitis	0.0016	0.00372	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Montelukast—allergic rhinitis	0.0016	0.00281	CcSEcCtD
Pasireotide—Diarrhoea—Cetirizine—allergic rhinitis	0.0016	0.00281	CcSEcCtD
Pasireotide—Vomiting—Loratadine—allergic rhinitis	0.00158	0.00277	CcSEcCtD
Pasireotide—Diarrhoea—Flunisolide—allergic rhinitis	0.00157	0.00276	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—TAC1—allergic rhinitis	0.00157	0.00363	CbGpPWpGaD
Pasireotide—Headache—Loratadine—allergic rhinitis	0.00155	0.00273	CcSEcCtD
Pasireotide—Abdominal pain—Montelukast—allergic rhinitis	0.00155	0.00272	CcSEcCtD
Pasireotide—Dizziness—Cetirizine—allergic rhinitis	0.00154	0.00271	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—TAC1—allergic rhinitis	0.00153	0.00355	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL5—allergic rhinitis	0.00152	0.00352	CbGpPWpGaD
Pasireotide—Dizziness—Flunisolide—allergic rhinitis	0.00152	0.00267	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—PTGDR2—allergic rhinitis	0.00149	0.00345	CbGpPWpGaD
Pasireotide—Vomiting—Cetirizine—allergic rhinitis	0.00148	0.00261	CcSEcCtD
Pasireotide—Nausea—Loratadine—allergic rhinitis	0.00147	0.00259	CcSEcCtD
Pasireotide—Headache—Cetirizine—allergic rhinitis	0.00146	0.00257	CcSEcCtD
Pasireotide—Vomiting—Flunisolide—allergic rhinitis	0.00146	0.00257	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—IL5—allergic rhinitis	0.00146	0.00338	CbGpPWpGaD
Pasireotide—Headache—Flunisolide—allergic rhinitis	0.00144	0.00253	CcSEcCtD
Pasireotide—Hyperglycaemia—Betamethasone—allergic rhinitis	0.00143	0.00252	CcSEcCtD
Pasireotide—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.00143	0.00252	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—IL5—allergic rhinitis	0.00142	0.0033	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TAC1—allergic rhinitis	0.00141	0.00327	CbGpPWpGaD
Pasireotide—Asthenia—Montelukast—allergic rhinitis	0.0014	0.00247	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—TAC1—allergic rhinitis	0.00139	0.00322	CbGpPWpGaD
Pasireotide—Nausea—Cetirizine—allergic rhinitis	0.00139	0.00244	CcSEcCtD
Pasireotide—Pruritus—Montelukast—allergic rhinitis	0.00138	0.00244	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00138	0.00319	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTGDR2—allergic rhinitis	0.00138	0.00319	CbGpPWpGaD
Pasireotide—Nausea—Flunisolide—allergic rhinitis	0.00136	0.0024	CcSEcCtD
Pasireotide—Diarrhoea—Montelukast—allergic rhinitis	0.00134	0.00236	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CCL11—allergic rhinitis	0.00133	0.00308	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00132	0.00306	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL5—allergic rhinitis	0.00131	0.00304	CbGpPWpGaD
Pasireotide—Dizziness—Montelukast—allergic rhinitis	0.00129	0.00228	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—IL5—allergic rhinitis	0.00129	0.00299	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TAC1—allergic rhinitis	0.00128	0.00297	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL11—allergic rhinitis	0.00127	0.00295	CbGpPWpGaD
Pasireotide—Vomiting—Montelukast—allergic rhinitis	0.00124	0.00219	CcSEcCtD
Pasireotide—Headache—Montelukast—allergic rhinitis	0.00123	0.00216	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—IL5—allergic rhinitis	0.00119	0.00276	CbGpPWpGaD
Pasireotide—Vertigo—Prednisolone—allergic rhinitis	0.00119	0.0021	CcSEcCtD
Pasireotide—Back pain—Triamcinolone—allergic rhinitis	0.00118	0.00207	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00117	0.00271	CbGpPWpGaD
Pasireotide—Vertigo—Hydrocortisone—allergic rhinitis	0.00116	0.00205	CcSEcCtD
Pasireotide—Nausea—Montelukast—allergic rhinitis	0.00116	0.00204	CcSEcCtD
Pasireotide—Hypertension—Prednisolone—allergic rhinitis	0.00114	0.00201	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—CCL11—allergic rhinitis	0.00113	0.00262	CbGpPWpGaD
Pasireotide—Alopecia—Dexamethasone—allergic rhinitis	0.00112	0.00198	CcSEcCtD
Pasireotide—Alopecia—Betamethasone—allergic rhinitis	0.00112	0.00198	CcSEcCtD
Pasireotide—Hypertension—Hydrocortisone—allergic rhinitis	0.00112	0.00197	CcSEcCtD
Pasireotide—Myalgia—Hydrocortisone—allergic rhinitis	0.0011	0.00194	CcSEcCtD
Pasireotide—Anxiety—Hydrocortisone—allergic rhinitis	0.0011	0.00193	CcSEcCtD
Pasireotide—Vertigo—Triamcinolone—allergic rhinitis	0.0011	0.00193	CcSEcCtD
Pasireotide—Vertigo—Methylprednisolone—allergic rhinitis	0.00109	0.00192	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00108	0.0025	CbGpPWpGaD
Pasireotide—Hypertension—Triamcinolone—allergic rhinitis	0.00105	0.00185	CcSEcCtD
Pasireotide—Hypertension—Methylprednisolone—allergic rhinitis	0.00105	0.00185	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CCL11—allergic rhinitis	0.00104	0.00242	CbGpPWpGaD
Pasireotide—Myalgia—Triamcinolone—allergic rhinitis	0.00104	0.00183	CcSEcCtD
Pasireotide—Myalgia—Methylprednisolone—allergic rhinitis	0.00104	0.00182	CcSEcCtD
Pasireotide—Arthralgia—Methylprednisolone—allergic rhinitis	0.00104	0.00182	CcSEcCtD
Pasireotide—Anxiety—Methylprednisolone—allergic rhinitis	0.00103	0.00182	CcSEcCtD
Pasireotide—Vertigo—Dexamethasone—allergic rhinitis	0.000994	0.00175	CcSEcCtD
Pasireotide—Vertigo—Betamethasone—allergic rhinitis	0.000994	0.00175	CcSEcCtD
Pasireotide—Hypotension—Hydrocortisone—allergic rhinitis	0.000988	0.00174	CcSEcCtD
Pasireotide—Insomnia—Prednisolone—allergic rhinitis	0.000979	0.00172	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—TAC1—allergic rhinitis	0.000965	0.00224	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000963	0.00169	CcSEcCtD
Pasireotide—Insomnia—Hydrocortisone—allergic rhinitis	0.000956	0.00168	CcSEcCtD
Pasireotide—Hypertension—Betamethasone—allergic rhinitis	0.000955	0.00168	CcSEcCtD
Pasireotide—Hypertension—Dexamethasone—allergic rhinitis	0.000955	0.00168	CcSEcCtD
Pasireotide—Myalgia—Betamethasone—allergic rhinitis	0.000942	0.00166	CcSEcCtD
Pasireotide—Myalgia—Dexamethasone—allergic rhinitis	0.000942	0.00166	CcSEcCtD
Pasireotide—Anxiety—Betamethasone—allergic rhinitis	0.000939	0.00165	CcSEcCtD
Pasireotide—Anxiety—Dexamethasone—allergic rhinitis	0.000939	0.00165	CcSEcCtD
Pasireotide—Hypotension—Methylprednisolone—allergic rhinitis	0.000928	0.00163	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—TAC1—allergic rhinitis	0.000925	0.00214	CbGpPWpGaD
Pasireotide—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000919	0.00162	CcSEcCtD
Pasireotide—Fatigue—Hydrocortisone—allergic rhinitis	0.000911	0.0016	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000907	0.00159	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000905	0.00159	CcSEcCtD
Pasireotide—Insomnia—Triamcinolone—allergic rhinitis	0.0009	0.00158	CcSEcCtD
Pasireotide—Insomnia—Methylprednisolone—allergic rhinitis	0.000898	0.00158	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—IL5—allergic rhinitis	0.000897	0.00208	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000864	0.00152	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—IL5—allergic rhinitis	0.00086	0.00199	CbGpPWpGaD
Pasireotide—Fatigue—Triamcinolone—allergic rhinitis	0.000858	0.00151	CcSEcCtD
Pasireotide—Fatigue—Methylprednisolone—allergic rhinitis	0.000856	0.00151	CcSEcCtD
Pasireotide—Hypotension—Dexamethasone—allergic rhinitis	0.000844	0.00148	CcSEcCtD
Pasireotide—Hypotension—Betamethasone—allergic rhinitis	0.000844	0.00148	CcSEcCtD
Pasireotide—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000836	0.00147	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000823	0.00145	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000823	0.00145	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—TAC1—allergic rhinitis	0.00082	0.0019	CbGpPWpGaD
Pasireotide—Insomnia—Dexamethasone—allergic rhinitis	0.000817	0.00144	CcSEcCtD
Pasireotide—Insomnia—Betamethasone—allergic rhinitis	0.000817	0.00144	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000812	0.00143	CcSEcCtD
Pasireotide—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000785	0.00138	CcSEcCtD
Pasireotide—Decreased appetite—Betamethasone—allergic rhinitis	0.000785	0.00138	CcSEcCtD
Pasireotide—Decreased appetite—Dexamethasone—allergic rhinitis	0.000785	0.00138	CcSEcCtD
Pasireotide—Fatigue—Dexamethasone—allergic rhinitis	0.000779	0.00137	CcSEcCtD
Pasireotide—Fatigue—Betamethasone—allergic rhinitis	0.000779	0.00137	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—IL5—allergic rhinitis	0.000763	0.00177	CbGpPWpGaD
Pasireotide—Asthenia—Hydrocortisone—allergic rhinitis	0.000758	0.00133	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—TAC1—allergic rhinitis	0.000757	0.00176	CbGpPWpGaD
Pasireotide—Pruritus—Hydrocortisone—allergic rhinitis	0.000748	0.00132	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000738	0.0013	CcSEcCtD
Pasireotide—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000738	0.0013	CcSEcCtD
Pasireotide—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000723	0.00127	CcSEcCtD
Pasireotide—Dizziness—Prednisolone—allergic rhinitis	0.000716	0.00126	CcSEcCtD
Pasireotide—Asthenia—Triamcinolone—allergic rhinitis	0.000714	0.00126	CcSEcCtD
Pasireotide—Abdominal pain—Betamethasone—allergic rhinitis	0.000714	0.00126	CcSEcCtD
Pasireotide—Abdominal pain—Dexamethasone—allergic rhinitis	0.000714	0.00126	CcSEcCtD
Pasireotide—Asthenia—Methylprednisolone—allergic rhinitis	0.000712	0.00125	CcSEcCtD
Pasireotide—Pruritus—Triamcinolone—allergic rhinitis	0.000704	0.00124	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—IL5—allergic rhinitis	0.000704	0.00163	CbGpPWpGaD
Pasireotide—Pruritus—Methylprednisolone—allergic rhinitis	0.000703	0.00124	CcSEcCtD
Pasireotide—Dizziness—Hydrocortisone—allergic rhinitis	0.000699	0.00123	CcSEcCtD
Pasireotide—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000679	0.00119	CcSEcCtD
Pasireotide—Headache—Prednisolone—allergic rhinitis	0.000678	0.00119	CcSEcCtD
Pasireotide—Vomiting—Hydrocortisone—allergic rhinitis	0.000672	0.00118	CcSEcCtD
Pasireotide—Headache—Hydrocortisone—allergic rhinitis	0.000662	0.00116	CcSEcCtD
Pasireotide—Dizziness—Triamcinolone—allergic rhinitis	0.000658	0.00116	CcSEcCtD
Pasireotide—Dizziness—Methylprednisolone—allergic rhinitis	0.000657	0.00115	CcSEcCtD
Pasireotide—Asthenia—Betamethasone—allergic rhinitis	0.000648	0.00114	CcSEcCtD
Pasireotide—Asthenia—Dexamethasone—allergic rhinitis	0.000648	0.00114	CcSEcCtD
Pasireotide—Nausea—Prednisolone—allergic rhinitis	0.000643	0.00113	CcSEcCtD
Pasireotide—Pruritus—Dexamethasone—allergic rhinitis	0.000639	0.00112	CcSEcCtD
Pasireotide—Pruritus—Betamethasone—allergic rhinitis	0.000639	0.00112	CcSEcCtD
Pasireotide—Vomiting—Triamcinolone—allergic rhinitis	0.000633	0.00111	CcSEcCtD
Pasireotide—Vomiting—Methylprednisolone—allergic rhinitis	0.000631	0.00111	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—SMAD3—allergic rhinitis	0.000631	0.00146	CbGpPWpGaD
Pasireotide—Nausea—Hydrocortisone—allergic rhinitis	0.000628	0.0011	CcSEcCtD
Pasireotide—Headache—Triamcinolone—allergic rhinitis	0.000624	0.0011	CcSEcCtD
Pasireotide—Headache—Methylprednisolone—allergic rhinitis	0.000622	0.00109	CcSEcCtD
Pasireotide—Diarrhoea—Dexamethasone—allergic rhinitis	0.000618	0.00109	CcSEcCtD
Pasireotide—Diarrhoea—Betamethasone—allergic rhinitis	0.000618	0.00109	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—SMAD3—allergic rhinitis	0.000605	0.0014	CbGpPWpGaD
Pasireotide—Dizziness—Betamethasone—allergic rhinitis	0.000597	0.00105	CcSEcCtD
Pasireotide—Dizziness—Dexamethasone—allergic rhinitis	0.000597	0.00105	CcSEcCtD
Pasireotide—Nausea—Triamcinolone—allergic rhinitis	0.000591	0.00104	CcSEcCtD
Pasireotide—Nausea—Methylprednisolone—allergic rhinitis	0.00059	0.00104	CcSEcCtD
Pasireotide—Vomiting—Dexamethasone—allergic rhinitis	0.000574	0.00101	CcSEcCtD
Pasireotide—Vomiting—Betamethasone—allergic rhinitis	0.000574	0.00101	CcSEcCtD
Pasireotide—Headache—Betamethasone—allergic rhinitis	0.000566	0.000995	CcSEcCtD
Pasireotide—Headache—Dexamethasone—allergic rhinitis	0.000566	0.000995	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—SMAD3—allergic rhinitis	0.000537	0.00124	CbGpPWpGaD
Pasireotide—Nausea—Betamethasone—allergic rhinitis	0.000536	0.000943	CcSEcCtD
Pasireotide—Nausea—Dexamethasone—allergic rhinitis	0.000536	0.000943	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—SMAD3—allergic rhinitis	0.000495	0.00115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NFKB1—allergic rhinitis	0.000321	0.000744	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NFKB1—allergic rhinitis	0.000308	0.000713	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NFKB1—allergic rhinitis	0.000273	0.000633	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—allergic rhinitis	0.000267	0.00062	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—allergic rhinitis	0.000256	0.000594	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NFKB1—allergic rhinitis	0.000252	0.000584	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—allergic rhinitis	0.000227	0.000527	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—allergic rhinitis	0.00021	0.000486	CbGpPWpGaD
